BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 31469428)

  • 1. Mesencephalic Astrocyte-Derived Neurotrophic Factor Inhibits Liver Cancer Through Small Ubiquitin-Related Modifier (SUMO)ylation-Related Suppression of NF-κB/Snail Signaling Pathway and Epithelial-Mesenchymal Transition.
    Liu J; Wu Z; Han D; Wei C; Liang Y; Jiang T; Chen L; Sha M; Cao Y; Huang F; Geng X; Yu J; Shen Y; Wang H; Feng L; Wang D; Fang S; Wang S; Shen Y
    Hepatology; 2020 Apr; 71(4):1262-1278. PubMed ID: 31469428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesencephalic astrocyte-derived neurotrophic factor is involved in inflammation by negatively regulating the NF-κB pathway.
    Chen L; Feng L; Wang X; Du J; Chen Y; Yang W; Zhou C; Cheng L; Shen Y; Fang S; Li J; Shen Y
    Sci Rep; 2015 Feb; 5():8133. PubMed ID: 25640174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small ubiquitin-related modifier 2/3 interacts with p65 and stabilizes it in the cytoplasm in HBV-associated hepatocellular carcinoma.
    Liu J; Sha M; Wang Q; Ma Y; Geng X; Gao Y; Feng L; Shen Y; Shen Y
    BMC Cancer; 2015 Oct; 15():675. PubMed ID: 26458400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small ubiquitin-related modifier 1 is involved in hepatocellular carcinoma progression via mediating p65 nuclear translocation.
    Liu J; Tao X; Zhang J; Wang P; Sha M; Ma Y; Geng X; Feng L; Shen Y; Yu Y; Wang S; Fang S; Shen Y
    Oncotarget; 2016 Apr; 7(16):22206-18. PubMed ID: 26993772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe Hepatitis Promotes Hepatocellular Carcinoma Recurrence via NF-κB Pathway-Mediated Epithelial-Mesenchymal Transition after Resection.
    Wu TJ; Chang SS; Li CW; Hsu YH; Chen TC; Lee WC; Yeh CT; Hung MC
    Clin Cancer Res; 2016 Apr; 22(7):1800-12. PubMed ID: 26655845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NKILA, a prognostic indicator, inhibits tumor metastasis by suppressing NF-κB/Slug mediated epithelial-mesenchymal transition in hepatocellular carcinoma.
    Chen R; Cheng Q; Owusu-Ansah KG; Song G; Jiang D; Zhou L; Xu X; Wu J; Zheng S
    Int J Biol Sci; 2020; 16(3):495-503. PubMed ID: 32015685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RMP promotes epithelial-mesenchymal transition through NF-κB/CSN2/Snail pathway in hepatocellular carcinoma.
    Zhou W; Wang Q; Xu Y; Jiang J; Guo J; Yu H; Wei W
    Oncotarget; 2017 Jun; 8(25):40373-40388. PubMed ID: 28423737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid (VPA) promotes the epithelial mesenchymal transition of hepatocarcinoma cells via transcriptional and post-transcriptional up regulation of Snail.
    Wu L; Feng H; Hu J; Tian X; Zhang C
    Biomed Pharmacother; 2016 Dec; 84():1029-1035. PubMed ID: 27768928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesencephalic astrocyte-derived neurotrophic factor inhibits oxygen-glucose deprivation-induced cell damage and inflammation by suppressing endoplasmic reticulum stress in rat primary astrocytes.
    Zhao H; Liu Y; Cheng L; Liu B; Zhang W; Guo YJ; Nie L
    J Mol Neurosci; 2013 Nov; 51(3):671-8. PubMed ID: 23760988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of UBAP2L Inhibits the Epithelial-Mesenchymal Transition via SNAIL1 Regulation in Hepatocellular Carcinoma Cells.
    Ye T; Xu J; Du L; Mo W; Liang Y; Xia J
    Cell Physiol Biochem; 2017; 41(4):1584-1595. PubMed ID: 28334716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinoma.
    Lin L; Chen S; Wang H; Gao B; Kallakury B; Bhuvaneshwar K; Cahn K; Gusev Y; Wang X; Wu Y; Marshall JL; Zhi X; He AR
    Theranostics; 2021; 11(9):4232-4250. PubMed ID: 33754058
    [No Abstract]   [Full Text] [Related]  

  • 12. Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis.
    Song R; Song H; Liang Y; Yin D; Zhang H; Zheng T; Wang J; Lu Z; Song X; Pei T; Qin Y; Li Y; Xie C; Sun B; Shi H; Li S; Meng X; Yang G; Pan S; Zhu J; Qi S; Jiang H; Zhang Z; Liu L
    Hepatology; 2014 Nov; 60(5):1659-73. PubMed ID: 25042864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apigenin inhibits NF-κB and snail signaling, EMT and metastasis in human hepatocellular carcinoma.
    Qin Y; Zhao D; Zhou HG; Wang XH; Zhong WL; Chen S; Gu WG; Wang W; Zhang CH; Liu YR; Liu HJ; Zhang Q; Guo YQ; Sun T; Yang C
    Oncotarget; 2016 Jul; 7(27):41421-41431. PubMed ID: 27203387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay between SUMO1-related SUMOylation and phosphorylation of p65 promotes hepatocellular carcinoma progression.
    Jiang C; Zhang C; Dai M; Wang F; Xu S; Han D; Wang Y; Cao Y; Liang Y; Zhang Z; Yan L; Shen Y; He K; Shen Y; Liu J
    Biochim Biophys Acta Mol Cell Res; 2024 Jan; 1871(1):119595. PubMed ID: 37730133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
    Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
    EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HAX-1 promotes the migration and invasion of hepatocellular carcinoma cells through the induction of epithelial-mesenchymal transition via the NF-κB pathway.
    Hu YL; Feng Y; Ma P; Wang F; Huang H; Guo YB; Li P; Mao QS; Xue WJ
    Exp Cell Res; 2019 Aug; 381(1):66-76. PubMed ID: 31047882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MANF protects human pancreatic beta cells against stress-induced cell death.
    Hakonen E; Chandra V; Fogarty CL; Yu NY; Ustinov J; Katayama S; Galli E; Danilova T; Lindholm P; Vartiainen A; Einarsdottir E; Krjutškov K; Kere J; Saarma M; Lindahl M; Otonkoski T
    Diabetologia; 2018 Oct; 61(10):2202-2214. PubMed ID: 30032427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydropyrimidine dehydrogenase predicts survival and response to interferon-α in hepatocellular carcinoma.
    Zhu WP; Liu ZY; Zhao YM; He XG; Pan Q; Zhang N; Zhou JM; Wang LR; Wang M; Zhan DH; Ma DN; Wang L
    Cell Death Dis; 2018 Jan; 9(2):69. PubMed ID: 29358721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRMT9 promotes hepatocellular carcinoma invasion and metastasis via activating PI3K/Akt/GSK-3β/Snail signaling.
    Jiang H; Zhou Z; Jin S; Xu K; Zhang H; Xu J; Sun Q; Wang J; Xu J
    Cancer Sci; 2018 May; 109(5):1414-1427. PubMed ID: 29603830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.